2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Christopher Kai Shun Leung: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metformin as a Neuroprotective Therapy for Glaucoma Metformin, Placebo - Glaucoma | Phase 2 | Recruiting | Christopher Kai Shun Leung | 125 | 2025-06-01 | 2025-11-20 |
| Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients Nicotinamide Riboside, Nicotinamide, Nicotinamide Mononucleotide - Glaucoma | Phase 2 | Recruiting | Christopher Kai Shun Leung | 138 | 2025-05-19 | 2025-06-26 |
Glaucoma (2)
Metformin (1) · Niacin (1) · Niacinamide (1) · Nicotinamide Mononucleotide (1) · Starch (1) · nicotinamide-beta-riboside (1)
Hong Kong (2)